Advanced search
Start date
Betweenand

Enhancing Health Value in Oncology: A Comprehensive Platform for Outcomes Collection, Economic Analyses, and Waste Management in High-Cost Treatments.

Abstract

Cancer remains one of the major public health problems worldwide, with an estimated 704,000 new cases per year between 2023-2025. Expenses related to high-cost treatments can account for up to 80% of total healthcare costs, alongside other high-cost care pathways. However, it is estimated that up to 30-40% of resources invested in cancer treatment are wasted on unnecessary and/or ineffective processes, people, procedures, consultations, and tests. These costs and wastage have a significant impact on the financial sustainability of healthcare systems and can compromise patients' access to effective and quality treatments, further highlighting the importance of solutions that enable efficient resource management and enhance the effectiveness of cancer treatment.The solution proposed in this project aims to address these issues by providing a personalized and innovative tool for outcome collection, economic analysis, and waste management in oncology treatment, with a focus on optimizing value in healthcare and improving patients' clinical outcomes. The platform developed in this project will combine clinical and cost data from patients with gynecological cancer, initially, to provide accurate information on the effectiveness and cost-effectiveness of different types of medications, care pathways, and procedures. Analysis of this data will assist physicians and managers in making more informed decisions regarding the most appropriate treatment for each patient, taking into consideration both clinical and economic outcomes (i.e., costs involved).Furthermore, the platform will also include tools for waste management in oncology. This will involve the identification and elimination of unnecessary or ineffective processes, procedures, consultations, and tests, as well as the optimization of resource utilization, such as recommended medications and medical equipment for treating patients with gynecological cancer. The platform will be developed in collaboration with physicians, managers, researchers, and healthcare experts, ensuring that the needs of patients and healthcare professionals are adequately considered. Additionally, the platform will be tested and validated in a real clinical setting, allowing for the evaluation of its effectiveness in improving the effectiveness of cancer treatment and, consequently, reducing unnecesary costs. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)